NWL Ranked #1 CHIR Grant

NWL’s grant application to the Canadian Institutes of Health Research (CHIR) is approved for $2.5 million+ and is ranked #1 nationwide by CHIR reviewers. The grant application is for further developing NWL’s proprietary dr-NSC stem cell technology. The PIs included in the grant are Dr. Cindi Morshead (UoT), Dr. Michael Fehlings (UHN), Dr. Ivar Mendez, Dr. Molly Stoichet (UoT), and Dr. Numa Dancause (UdeM).

A first-in-class approach to stop & reverse cell, tissue and organ degeneration Une approche de premier ordre ...

New autologous neural stem cells with the potential to realize the treatment promise of stem cell ...

A biomaterial for regenerating multiple tissues in accordance with the original organization and layering of the ...

COLLABORATORS